Which presents a good entry opportunity. I think it’s a good strategy to buy sm1 after Ann and sell before next Ann comes out. 10-25% decent return for 6 months if you are not greedy
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025